Precedex Injection, Solution
Product Images NDC 0409-1174

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Precedex (NDC 0409-1174). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hospira, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Precedex 01)

Chemical structure of dexmedetomidine hydrochloride, illustrating its molecular configuration with labeled atoms and a hydrochloride component indicated by HCl.*

FDA Label Image

Logo (Precedex 02)

FDA Label Image

Principal Display Panel (50 mL Bottle Label)

Precedex 4 mcg/mL dexmedetomidine hydrochloride injection label for intravenous use. The 50 mL single-dose bottle contains 200 mcg/50 mL concentration in 0.9% sodium chloride. Label includes storage instructions, lot and expiration date placeholders, and manufacturer Hospira, Inc.*

FDA Label Image

Principal Display Panel (50 mL Bottle Tray)

Packaging label for Precedex 200 mcg/50 mL (4 mcg/mL) injection, solution. The label states dexmedetomidine hydrochloride in 0.9% sodium chloride injection for intravenous use. It is a single-dose bottle containing 20 units x 50 mL. The labeler is Hospira, Inc., and the NDC is 0409-1454-20. The label includes handling and usage instructions, warnings about discarding unused portions, and the Novaplus trademark.*

FDA Label Image

Principal Display Panel (20 mL Vial Label)

Label for Precedex 4 mcg/mL (80 mcg/20 mL) injection, solution for intravenous use. Contains Dexmedetomidine HCl in 0.9% Sodium Chloride Injection. Single-dose vial, 20 mL. Distributed by Hospira, Inc., Lake Forest, IL. Includes dosage information and storage instructions, highlighting that the product is preservative-free.*

FDA Label Image

Principal Display Panel (20 mL Vial Carton)

Precedex 4 mcg/mL injection solution label showing a single-dose vial containing 80 mcg/20 mL of dexmedetomidine hydrochloride in 0.9% sodium chloride. The label includes dosage strength, volume, and directions for intravenous use, distributed by Hospira, Inc., with the Novaplus logo.*

FDA Label Image

Principal Display Panel (100 mL Bottle Label)

Precedex 4 mcg/mL (400 mcg/100 mL) injection, a dexmedetomidine hydrochloride in 0.9% sodium chloride solution for intravenous use. The label states single-dose bottle usage and discarding unused portions. Manufactured by Hospira, Inc., the label includes storage instructions and dosage information.*

FDA Label Image

Principal Display Panel (100 mL Bottle Tray)

Precedex 4 mcg/mL (400 mcg/100 mL) intravenous injection solution, Dexmedetomidine HCl in 0.9% sodium chloride. Single-dose bottle, 100 mL vial with 10 units per carton. Labeler is Hospira, Inc., with additional Novaplus branding. Storage and dosage instructions are included on the label.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.